23 results
8-K
ADAP
Adaptimmune Therapeutics Plc
8 Apr 20
Departure of Directors or Certain Officers
8:06am
, meets the independence requirements of Rule 10A-3 under the Securities Exchange Act of 1934, as amended, and the applicable Nasdaq rules.
Mr. Kerr
20-F
EX-4.13
bal h7vzgzwlxbtl
13 Oct 15
Annual report (foreign)
12:00am
DRS
wlmaiuw3j0wlq5m417
5 Feb 15
Draft registration statement
12:00am
20-F
c7o5wpeb cqzkyo12c4y
13 Oct 15
Annual report (foreign)
12:00am
10-K
2v5t19d4bj3q t663
13 Mar 17
Annual report
12:00am